![\"\"](\"https:\/\/static.stocktitan.net\/img\/icons\/Google_News_icon.svg\"){kind=icon}
<\/p>\nKey Terms<\/p>\n
\n
\n glyphosate
\n
\n technical
\n
\n
<\/p>\n
A broad\u2011spectrum herbicide used widely to kill weeds and grasses in farming and landscaping; think of it as a powerful weed killer farmers spray to protect crop rows. Investors care because rules, health or environmental concerns, or large lawsuits can change how much farmers use it, alter crop yields and input costs, and affect sales and legal exposure for chemical and agricultural businesses.<\/p>\n
<\/p>\n
\n
\n go-to-market strategies
\n
\n technical
\n
\n
<\/p>\n
A go-to-market strategy is a company’s plan for how it will sell a product or service to customers \u2014 who the target buyers are, which channels and messages will reach them, and how the company will price and deliver the offering. Think of it as the recipe and route map for turning a new idea into paying customers. Investors watch these plans because they directly affect how fast a product can grow, how much it will cost to acquire customers, and whether the company can win against competitors.<\/p>\n
<\/p>\n
\n
\n commodity-based market
\n
\n technical
\n
\n
<\/p>\n
A commodity-based market is one where raw physical goods \u2014 like oil, metals, agricultural products, or natural gas \u2014 are the main items being bought and sold, and prices are driven by supply, demand, weather, production and storage. Investors care because these markets influence costs for many businesses and can be volatile; watching them is like tracking weather for a farmer \u2014 small changes can quickly affect profits, inflation and investment returns.<\/p>\n
<\/p>\n
\n
\n crop protection
\n
\n technical
\n
\n
<\/p>\n
Crop protection covers the products and practices\u2014such as chemical treatments, biological controls, resistant seeds and farm methods\u2014that keep crops safe from pests, weeds and disease. For investors it matters because these tools directly affect farm yields, input sales, regulatory risk and long-term demand for agricultural technology; think of crop protection as a shield that helps secure harvests and the revenues that depend on them.<\/p>\n
<\/p>\n
\n
\n
<\/p>\n
<\/p>\n
\n
\n See more from StockTitan in Google Search and AI answers.
\n Adds StockTitan as a preferred source \u00b7 opens Google
\n <\/p>\n
\n
\n
\n
<\/p>\n
07\/01\/2026 – 06:33 PM<\/p>\n
Advances key component of Crop Science division\u2019s Five-Year Framework strategy<\/p>\n
Reinforces commitment to delivering trusted Roundup\u00ae brands and glyphosate products and services to U.S. customers<\/p>\n
LEVERKUSEN, Germany & ST. LOUIS–(BUSINESS WIRE)–
\nBayer Group today announced the consolidation of the U.S. glyphosate business into Ruveon LLC to optimize and align the business with the specific needs of the U.S. market environment. Ruveon will focus on all aspects of U.S. glyphosate, pricing, go-to-market strategies, production and logistics and will be solely responsible for the U.S. glyphosate business. Ruveon is based in St. Louis, Missouri, and remains a Bayer Group business.<\/p>\n
\nThe consolidation of the U.S. glyphosate business is an executional step within the Crop Science division\u2019s comprehensive Five-Year Framework, previously announced and established by Bayer Group to drive growth, resilience and profitability and allow an even sharper focus on innovation and business operations. As part of the Five-Year Framework, Bayer Group continues to work to optimize the crop protection businesses in a very competitive environment.<\/p>\n
\nRuveon is expected to be a more nimble and well-positioned player within its commodity-based market, which requires a specialized approach to address competitive dynamics. The dedicated product and commercial teams for the U.S. glyphosate business are now part of Ruveon. The company is expected to supply the U.S. agriculture industry with critical glyphosate products and the highest standards of quality and service.<\/p>\n
\n\u201cToday we take an important step within our Five-Year Framework,\u201d said Brian Naber, Head of Crop Science North America & Australia\/New Zealand. \u201cRuveon\u2019s launch is a sign of our ongoing commitment to excellence in the glyphosate market. Consolidating U.S. glyphosate resources and operations benefits customers, partners and other stakeholders by enabling the Ruveon and Bayer Group teams to fully dedicate the appropriate focus and resources to best meet and anticipate our respective customers\u2019 needs.\u201d<\/p>\n
\nAlfonso Alba Ord\u00f3\u00f1ez joins Ruveon as Chief Executive Officer with over 30 years of executive leadership experience with Bayer Group in the global agricultural industry. His career spans senior leadership positions across Europe, South America, North America and China, where he has consistently guided organizations through complex commercial and business transformations, helping them implement strategy and deliver sustained growth.<\/p>\n
\nSteve Knodle serves as Executive Vice President, Head of Commercial Business at Ruveon. With over 28 years of agricultural industry experience across domestic and international businesses, Steve will oversee Ruveon\u2019s U.S. glyphosate commercial sales and marketing teams across agricultural and industrial, turf and ornamental businesses.<\/p>\n
\nAbout Bayer<\/p>\n
\nBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, \u201cHealth for all, Hunger for none,\u201d the company\u2019s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros. For more information, go to www.bayer.com<\/a>.<\/p>\n \nAbout Ruveon<\/p>\n \nRuveon offers glyphosate-based agricultural solutions vital for the security and affordability of the food supply. Based in St. Louis, Ruveon delivers trusted solutions like Roundup\u00ae and drives value to growers across the United States. The business\u2019 core values \u2013 Performance, Reliability and Adaptability \u2013 guide its mission to empower growers to unlock their full potential. For more information, visit www.ruveon.com<\/a>.<\/p>\n \nFind more information at www.bayer.com<\/a>.<\/p>\n \nForward-Looking Statements<\/p>\n \nThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer\u2019s public reports which are available on the Bayer website at www.bayer.com<\/a>. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.<\/p>\n \nBayer AG is a holding company with operating subsidiaries worldwide. References to \u201cBayer\u201d or \u201cthe company\u201d herein may refer to one or more subsidiaries as context requires.<\/p>\n View source version on businesswire.com: https:\/\/www.businesswire.com\/news\/home\/20260701782418\/en\/<\/a><\/p>\n \nContact for media inquiries: \nContact for investor inquiries: Source: Bayer<\/p>\n","protected":false},"excerpt":{"rendered":"Key Terms
glyphosate
technical
A broad\u2011spectrum herbicide used widely to kill weeds and…\n","protected":false},"author":2,"featured_media":48566,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21161],"tags":[21182,34703,22115,40436,22644,40435,27579],"class_list":["post-48565","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bayer","tag-bayer","tag-bayry","tag-crop-science","tag-five-year-framework","tag-glyphosate","tag-ruveon","tag-u-s-market"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/48565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/comments?post=48565"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/48565\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media\/48566"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media?parent=48565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/categories?post=48565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/tags?post=48565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/p>\n
\n
Brian Leake, phone +1 314 370 3285
\n
Email: brian.leake@bayer.com<\/a><\/p>\n
\n
Bayer Investor Relations Team, phone +49 214 30-72704
\n
Email: ir@bayer.com
\n<\/a>
www.bayer.com\/en\/investors\/ir-team<\/a><\/p>\n